Home
Justin B. Klee, Co-CEO: Amylyx Pharmaceuticals AMLX Sell · Filed 23/03/20
Trade details
- Type
- Insider sale
- Amount
- $3,074,311.2
- Shares · price
- 96,555 sh · $31.84 a share
- Held after
- 2,796,062 sh
- Person
- Justin B. KleeCo-CEO
- Trade date
- 23/03/16
- Filed
- 23/03/20
- Days to filing
- 4 days
Sold 3.3% of holdings
- Share of holding sold
- 3.3%
Amylyx Pharmaceuticals trades, last 26 weeks
What else happened in Amylyx Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/02/14~23/04/15Justin B. Klee's recent trades
- Justin B. Klee
Planned saleAmylyx Pharmaceuticals
Planned saleAmylyx Pharmaceuticals
AMLX
$980.3K
30,464 sh
$980.3K
Filed 09/11
Traded 09/10
- Justin B. Klee
SellAmylyx Pharmaceuticals
SellAmylyx Pharmaceuticals
AMLX
$423.7K
29,282 sh
$423.7K
Filed 03/04
Traded 03/02
- Justin B. Klee
Planned saleAmylyx Pharmaceuticals
Planned saleAmylyx Pharmaceuticals
AMLX
$423.8K
29,282 sh
$423.8K
Filed 03/02
Traded 03/02
- Justin B. Klee
SellAmylyx Pharmaceuticals
SellAmylyx Pharmaceuticals
AMLX
$227.7K
15,500 sh
$227.7K
Filed 02/04
Traded 02/02
- Justin B. Klee
Planned saleAmylyx Pharmaceuticals
Planned saleAmylyx Pharmaceuticals
AMLX
$227.6K
15,500 sh
$227.6K
Filed 02/02
Traded 02/02